1. Home
  2. HRMY vs VYX Comparison

HRMY vs VYX Comparison

Compare HRMY & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.82

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$10.52

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
VYX
Founded
2017
1881
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.6B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
VYX
Price
$37.82
$10.52
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$51.33
$15.17
AVG Volume (30 Days)
695.1K
2.3M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$2,653,000,000.00
Revenue This Year
$23.11
N/A
Revenue Next Year
$16.15
N/A
P/E Ratio
$12.04
N/A
Revenue Growth
21.13
N/A
52 Week Low
$25.52
$7.55
52 Week High
$40.93
$14.67

Technical Indicators

Market Signals
Indicator
HRMY
VYX
Relative Strength Index (RSI) 54.65 53.55
Support Level $37.12 $10.19
Resistance Level $39.60 $10.62
Average True Range (ATR) 1.15 0.33
MACD -0.38 0.10
Stochastic Oscillator 17.33 75.56

Price Performance

Historical Comparison
HRMY
VYX

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: